arrow
返回
G

Guntram Schernthaner

rudolfstiftung hospital

70H指数
304论文数
2.1W被引数
收录论文 102
发表时间
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor TherapyFinerenone主要用于有或没有钠-葡萄糖Cotransporter-2抑制剂治疗的晚期CKD和2型糖尿病
err2022-01-01
err96
errOAAI
errRossing, Peter; Filippatos, Gerasimos; Agarwal, Rajiv; Anker, Stefan D.; Pitt, Bertram; Ruilope, Luis M.; Chan, Juliana C. N.; Kooy, Adriaan; McCafferty, Kieran; Schernthaner, Guntram; Wanner, Christoph; Joseph, Amer; Scheerer, Markus F.; Scott, Charlie; Bakris, George L.
err分享
err收藏
Finerenone in Patients with CKD and T2D by SGLT-2i Treatment: An Analysis of the FIDELIODKD Study
err2021-12-01
err0
PREAI
errRossing, Peter; Agarwal, Rajiv; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Chan, Juliana; Kooy, Adriaan; McCafferty, Kieran; Schernthaner, Guntram; Wanne, Christoph
err分享
err收藏
The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
err2021-10-01
err9
errOAAI
errCzupryniak, Leszek; Dicker, Dror; Lehmann, Roger; Prazny, Martin; Schernthaner, Guntram
err分享
err收藏
Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study
err2021-06-01
err0
PREAI
errRossing, Peter; Agarwal, Rajiv; Anker, Stefan; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Chan, Juliana C.; Kooy, Adriaan; Mccafferty, Kieran; Schernthaner, Guntram; Wanner, Christoph; Joseph, Amer; Scheerer, Markus F.; Scott, Charlie; Bakris, George
err分享
err收藏
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
err2020-10-23
err105
errOAAI
errSchernthaner, Guntram; Shehadeh, Naim; Ametov, Alexander S.; Bazarova, Anna V.; Ebrahimi, Fahim; Fasching, Peter; Janez, Andrej; Kempler, Peter; Konrade, Ilze; Lalic, Nebojsa M.; Mankovsky, Boris; Martinka, Emil; Rahelic, Dario; Serafinceanu, Cristian; Skrha, Jan; Tankova, Tsvetalina; Visockiene, Zydrune
err分享
err收藏
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
err2020-04-28
err11
errOAAI
errBethel, M. Angelyn; Stevens, Susanna R.; Buse, John B.; Choi, Jasmine; Gustavson, Stephanie M.; Iqbal, Nayyar; Lokhnygina, Yuliya; Mentz, Robert J.; Patel, Rishi A.; Ohman, Peter; Schernthaner, Guntram; Lecube, Albert; Hernandez, Adrian F.; Holman, Rury R.
err分享
err收藏
err分享
err收藏
The right place for metformin today
err2020-01-01
err50
PREAI
errSchernthaner, Guntram; Schernthaner, Gerit-Holger
err分享
err收藏
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
err2019-08-31
err9
errOAAI
errSchernthaner, Guntram; Karasik, Avraham; Abraitiene, Agne; Ametov, Alexander S.; Gaal, Zsolt; Gumprecht, Janusz; Janez, Andrej; Kaser, Susanne; Lalic, Katarina; Mankovsky, Boris N.; Moshkovich, Evgeny; Past, Marju; Prazny, Martin; Radulian, Gabriela; Duvnjak, Lea Smircic; Tkac, Ivan; Trusinskis, Karlis
err分享
err收藏
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle
err2019-07-01
err6
errOAAI
errSchernthaner, Guntram; Wanner, Christoph; Jurisic-Erzen, Dubravka; Guja, Cristian; Gumprecht, Janusz; Jarek-Martynowa, Iwona R.; Karasik, Avraham; Lalic, Nebojsa; Mankovsky, Boris N.; Prazny, Martin; Tankova, Tsvetalina; Tsur, Anat; Wascher, Thomas C.; Wittmann, Istvan
err分享
err收藏
Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures
err2019-06-24
err23
errOAAI
errBrix, Johanna Maria; Kopp, Hans-Peter; Hoellerl, Florian; Schernthaner, Gerit Holger; Ludvik, Bernhard; Schernthaner, Guntram
err分享
err收藏
Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?
err2018-11-21
err14
errOAAI
errSchernthaner, Guntram; Lotan, Chaim; Baltadzhieva-Trendafilova, Elina; Ceponis, Jonas; Clodi, Martin; Ducena, Kristine; Goncalvesova, Eva; Guja, Cristian; Honka, Marek; Janez, Andrej; Lalic, Nebojsa; Lehmann, Roger; Nyolczas, Noemi; Pauklin, Priit; Rynkiewicz, Andrzej; Sergienko, Igor; Duvnjak, Lea Smircic
err分享
err收藏
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
err2018-02-07
err62
errOAAI
errSchernthaner, Guntram; Schernthaner-Reiter, Marie Helene
err分享
err收藏
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
err2017-10-23
err9
errOAAI
errSchernthaner, Guntram; Lehmann, Roger; Prazny, Martin; Czupryniak, Leszek; Ducena, Kristine; Fasching, Peter; Janez, Andrej; Karasik, Avraham; Kempler, Peter; Martinka, Emil; Shestakova, Marina V.; Duvnjak, Lea Smircic; Tankova, Tsvetalina
err分享
err收藏
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial
err2017-07-31
err118
errOAAI
errGroop, Per-Henrik; Cooper, Mark E.; Perkovic, Vlado; Hocher, Berthold; Kanasaki, Keizo; Haneda, Masakazu; Schernthaner, Guntram; Sharma, Kumar; Stanton, Robert C.; Toto, Robert; Cescutti, Jessica; Gordat, Maud; Meinicke, Thomas; Koitka-Weber, Audrey; Thiemann, Sandra; von Eynatten, Maximilian
err分享
err收藏
err分享
err收藏
Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013
err2017-03-09
err17
PREAI
errHolden, S. E.; Jenkins-Jones, S.; Morgan, C. Ll.; Peters, J. R.; Schernthaner, G.; Currie, C. J.
err分享
err收藏
IMPACT OF CHANGES IN GLUCOSE-LOWERING THERAPY ON ANALYSES OF GLYCEMIC CONTROL AND WEIGHT IN EMPA-REG OUTCOME
err2016-09-01
err0
PREAI
errLee, Dae Wook; Schernthaner, Guntram; Scheen, Andre; Johansen, Odd Erik; Zinman, Bernard
err分享
err收藏